Bardzo tanie apteki z dostawą w całej Polsce kupic cialis i ogromny wybór pigułek.

Dokument

PUBLIKATIONEN 2010
Aigner M, Ossege M, Freidl M and Wancata J (2010) Psychopharmakotherapie der Essstörungen. Einsatz, Wirkung und Bedeutung der medikamentösen Behandlung. Psychopraxis 13:14-17 (IF: 0) Aigner M, Friedrich F, Piralic-Spitzl S, Freidl M, Wancata J, Ossege M (2010) Von der Symptompräsentation zur Diagnose im CL-Dienst. Spectrum Psychiatrie 1:16-18 (IF: 0) Aigner M (2010) Störung der Schmerz- und Stressverarbeitung. Klinik 20: 18-19 (IF: 0) Amminger PG, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, McKinnon A, McGorry PD, Berger G (2010) Long-Chain Omega-3 Fatty Acids for Indicated Prevention of Psychotic Disorders: A Randomized, Placebo-Controlled Trial. Archives of General Psychiatry 67:146-54 (IF: 12.257) Anderer P, Moreau A, Woertz M, Ross M, Gruber G, Parapatics S, Loretz E, Heller E, Schmidt A, Boeck M, Moser D, Kloesch G, Saletu B, Saletu-Zyhlarz GM, Danker-Hopfe H, Zeitlhofer J, Dorffner G (2010) Computer-assisted sleep classification according to the standard of the American Academy of Sleep Medicine: validation study of the AASM version of Somnolyzer 24x7. Neuropsychobiology 62: 250-264 (IF: 2.147) Baewert A, Metz V, Fischer G (2010) Substanzabhängigkeit vom Opioidtyp – Behandlung mit oralen retardierten Morphinen. Suchttherapie 11: 121-128 (IF: 0.326) Bauer SM, Schanda H (2010) Die Bedeutung der medikamentösen Rückfallprophylaxe nach Entlassung aus dem Maßnahmenvollzug gemäß § 21 Abs. 1 StGB - Ein Fallbericht. Journal für Neurologie, Neurochirurgie und Psychiatrie 4: 80-82 (IF: 0) Danker-Hopfe H, Dorn H, Bahr A, Anderer P, Sauter C (2010) Effects of electromagnetic fields emitted by mobile phones (GSM 900 and WCDMA/UMTS) on the macrostructure of sleep. Journal of Sleep Research 20: 73-81 (IF: 3.500) Demal U (2010) Zwangsstörungen: Behandlung durch Kognitive Verhaltenstherapie. Jatros Neurologie & Psychiatrie 1: 40-42 (IF: 0) Demal U, Aigner M, Dold M (2010) Das Messie-Syndrom. Psychopraxis 13: 14-16 (IF: 0) Demal U, Artych A (2010) DBT – ein störungsspezifisches Behandlungskonzept. Spectrum Psychiatrie 3: 30-32 (IF: 0) Dold M, Lenz G, Demal U, Aigner M (2010) Monitoring- und Feedback-Systeme in der Psychotherapie. Psychotherapieforum 18: 208-214 (IF: 0) Emre M, Tsolaki M, Bonuccelli U, Destee A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladström A, Jones R, on behalf of the 11018 Study Investigators (2010) Memantine for patients with Parkinson´s disease dementia or dementia with Lewy bodies: a randomized, double-blind, placebo-controlled trial. Lancet Neurology 9: 969-977 (IF: 18.126) Falkenstetter T, Frauscher B, Anderer P, Bolitschek J, Fugger B, Holzinger B, Kerbl R, Klösch G, Lehofer M, Mallin W, Moser D, Pavelka R, Popovic R, Saletu A, Saletu B, Zeitlhofer J, Högl B (2010) Erhöhte Tagesschläfrigkeit in Österreich. Prävalenz und Risikofaktoren. Somnologie 14: 15-22 (IF: 0) Fischer G (2010) Sucht und Gender. Sucht 56: 91-93 (IF: 0) Fischer-Kern M, Kapusta ND, Doering S, Hörz S, Mikutta C, Aigner M (2010) The Relationship between Personality Organization and Psychiatric Classification in Chronic Pain Patients. Psychopathology 44: 21-26 (IF: 1.637) Fischer-Kern M, Mikutta C, Kapusta ND, Hörz S, Naderer A, Thierry N, Leithner-Dziubas K, Löffler-Stastka H, Aigner M (2010) The psychic structure of chronic pain patients. Zeitschrift für Psychosomatische Medizin und Psychotherapie 56: 34-46 (IF: 0) Freidl M, Unger A, Vyssoki B, Wancata J (2010) Gender-Aspekte psychiatrischer Publikationen. Neuropsychiatrie 4: 1-8 (IF: 1.381) Freidl M, Piralic-Spitzl S, Aigner M (2010) EACLPP und ECPR 2010. Spectrum Psychiatrie: 52-53 (IF: 0) Friedrich F, Freidl M, Wancata J (2010) Somatische Komorbidität bei psychisch Kranken. ÄrzteKrone 4: 26-29 (IF: 0) Friedrich F, Mlczoch-Czerny MT, Spiegel W (2010) Berufswunsch Psychiatrie – Rekrutierung von ÄrztInnen zur Weiterbildung in Österreich. Psychiatrische Praxis 37: 248-251 (IF 1.174) Friedrich F, Wenzel T (2010) Transkulturelle Aspekte traumatischer Erlebnisse – Überlegungen und Implikationen. C.G. Jung-Forum 4: 27-34. (IF: 0) Frühwald S, Karner A, Seyringer ME, Skribe T, Frottier P, Entenfellner A (2010) Quality assurance of take-over from in-patient to out-patient care: experiences in Lower Austria. Neuropsychiatrie 24: 195-9 (IF: 1.381) Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Schosser A, Ball HA, Tozzi F, Perry J, Muglia P, Kennedy JL, King N, Vincent JB, Parikh SV, Strauss J, Craig IW, McGuffin P, Farmer A (2010) Association analysis of DAOA and DAO in bipolar disorder: results from two independent case-control studies. Bipolar Disorders 12: 579-581 (IF: 5.502) Godlewska B, Olajossy-Hilkesberger L, Limon J, Landowski J (2010) Ser9Gly polymorphism of the DRD3 gene is associated with worse premorbid social functioning and an earlier age of onset in female but not male schizophrenic patients. Psychiatry Research 15: 266-267 (IF: 2.373) Grunze H, Vieta E, Goodwin G, Bowden C, Licht R, Möller HJ, Kasper S on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders J, Whybrow P, Yamada K) (2010) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders: Update 2010 on the treatment of acute bipolar depression. The World Journal of Biological Psychiatry 11: 81-109 (IF: 5.564) Hahn A, Lanzenberger R, Wadsak W, Spindelegger C, Moser U, Mien LK, Mitterhauser M, Kasper S (2010) Escitalopram enhances the association of serotonin-1A receptors to heteroceptors in anxiety disorders. Journal of Neuroscience 30: 14482-14489 (IF: 7.178) Haeusler D, Nics L, Mien L-K, Ungersboeck J, Lanzenberger R, Shanab K, Sindelar KM, Viernstein H, Wagner K-H, Dudczak R, Kletter K, Wadsak W, Mitterhauser M (2010) [18F][email protected] and [18F][email protected]:2 - Metabolic considerations. Nuclear Medicine and Biology 37: 421-426 (IF: 2.456) Höfer P, Friedrich F, Vyssoki B, Spindelegger C, Schmook M, Barnas C, Lesch O, Walter H (2010) Hyperprolactinaemia in a patient with acute psychosis: prolactinoma or medication induced phenomenon. The World Journal of Biological Psychiatry 11: 759-761 (IF 5.564) Höflich A, Moser U, Savli M, Hahn A, Hofer-Irmler I, Kasper S, Lanzenberger R (2010) Tiefe Einblicke. Bildgebung in der Psychiatrie. CliniCum neuropsy 4: 18-22 (IF: 0) Jones H, Kaltenbach K, Heil S, Coyle M, Arria A, O`Grady K, Selby P, Martin P, Fischer G (2010) Prenatal Exposure to Buprenorphine versus Methadone: Effects on neonatal Abstinence Syndrom. New England Journal of Medicine 363: 2320-2331 (IF: 47.050) Kaiser G, Unger A, Marquart B, Weiss M, Freidl M, Wancata J (2010) The German language version of the Camberwell Assessment of Need for the Elderly (CANE) among dementia patients. Neuropsychiatrie 24: 182-189 (IF: 1.381) Kapusta ND, Pietschnig J, Plener PL, Blüml V, Lesch OM, Walter H (2010) Does Breath Carbon Monoxide Measure Nicotine dependence? Journal of Addictive Diseases 29: 493-499 (IF: 1.234) Kasess CH, Stephan KE, Weissenbacher A, Pezawas L, Moser E, Windischberger C (2010) Multi-subject analyses with dynamic causal modeling. NeuroImage 49: 3065-3074 (IF: 5.739) Kasper S (2010) Begriffsverwirrung in der Psychopharmakologie. Trends & Perspektiven in der Psychiatrie. Journal für Neurologie, Neurochirurgie und Psychiatrie 11: 4-5 (IF: 0) Kasper S (2010) Ginkgo biloba has a proven benefit. Alzheimer’s Research & Therapy 2: 30 (IF: 0) Kasper S (2010) The proof of efficacy in psychopharmacology: clinical studies, metaanalysis and evidence-based medicine. European Archives of Psychiatry and Clinical Neuroscience 260: 1 (IF : 2.747) Kasper S (2010) Wirkt Ginkgo-Extrakt bei Alzheimer Demenz? Studienlage und praktische Erfahrungen. Phytotherapie Austria 4: 4-6 (IF: 0) Kasper S, Caraci F, Forti B, Drago F, Aguglia E (2010) Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. European Neuropsychopharmacology 20: 747-765 (IF: 3.684) Kasper S, Gastpar M, Möller HJ, Müller WE, Volz HP, Dienel A, Kieser M (2010) Better tolerability of St. John’s wort extract WS® 5570 compared to treatment with SSRIs: a re-analysis of data from controlled clinical trials in acute major depression. International Clinical Psychopharmacology 25: 204-213 (IF: 3.345) Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Dienel A, Schläfke S (2010) Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder – a randomised, double-blind, placebo controlled trial. International Clinical Psychopharmacology 25: 277-287 (IF: 3.345) Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Dienel A, Schläfke S (2010) Efficacy and safety of silexan, a new orally administered lavender oil preparation, in subthreshold anxiety disorder – evidence from clinical trials. Wiener Medizinische Wochenschrift 160: 547-556 (IF: 0) Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo-Gonzalez AL, Smeraldi E, Rybakowsky J, Quera Salva MA, Wirz-Justice A, Picarel-Blachot F, Bayle F (2010) Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle, depressive and anxiety symptoms in patients with major depressive disorder. A randomized, double-blind comparison with sertraline. The Journal of Clinical Psychiatry 71: 109-120 (IF: 5.218) Kasper S, Möller HJ, Hale A (2010) The European Post-marketing Observational Serdolect (EPOS) study: an investigation of the safety of antipsychotic drug treatment. European Archives of Psychiatry and Clinical Neuroscience 260: 59-68 (IF : 2.747) Kasper S, Montgomery SA, Möller HJ, van Oers HJJ, Schutte AJ, Vrijland P, van der Meulen E (2010) Longitudinal analysis of the suicidal behavior risk in placebo-controlled studies of mirtazapine in major depressive disorder. The World Journal of Biological Psychiatry 11: 36-44 (IF: 5.564) Kasper S, Pail G (2010) Milnacipran: a unique antidepressant? Neuropsychiatric Disease and Treatment 6 (Suppl. 1): 23-31 (IF: 0) Kaufmann RM, Kraft B, Frey R, Winkler D, Weiszenbichler S, Bäcker C, Kasper S, Kress HG (2010) Acute psychotropic effects of oral cannabis extract with a defined content of Δ9-tetrahydrocannabinol (THC) in healthy volunteers. Pharmacopsychiatry 43: 24-32 (IF: 2.317) Kaufmann RM, Schanda H (2010) Die Situation psychisch gestörter Straftäter in Österreich. Jatros Neurologie & Psychiatrie 2: 24-26 (IF: 0) Kocabas NA, Antonijevic I, Faghel C, Forray C, Kasper S, Lecrubier Y, Linotte S, Massat I, Montgomery S, Noro M, Oswald P, Snyder L, Souery D, Zohar J, Mendlewicz J (2010) Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes. The World Journal of Biological Psychiatry 11: 985-990 (IF: 5.564) Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I (2010)) The Impact of Catechol-O-methyltransferase (COMT) SNPs and Haplotypes on Treatment Response Phenotypes in Major Depressive Disorder: a case-control association study. International Clinical Psychopharmacology 25: 218-227 (IF: 3.345) Kogoj D, Lesch OM (2010) Die individuelle Entzugsbehandlung von Alkoholabhängigen nach der Lesch-Typologie. Der Mediziner 5: 30 (IF: 0) Kogoj D, Lesch OM, Blüml V, Riegler A, Vyssoki B, Schlaff G, Walter H (2010) Lesch Alcoholism Typology Medical Treatment and Research. Archives of Psychiatry and Psychotherapy 4: 37-48 (IF: 0) Konstantinidis A, Spindelegger C, Kasper S (2010) SJS unter Carbamazepin beim HLA-B*1502-Allel. CliniCum neuropsy 1: 38-39 (IF: 0) Kranz GS, Kasper S, Lanzenberger R (2010) Reward and the serotonergic system. Neuroscience 166: 1023-1035 (IF: 3.292) Kranz G, Shamim EA, Lin PT, Kranz GS, Hallett M (2010) Deep transcranial magnetic brain stimulation modulates blepharospasm: A randomized sham-controlled study. Neurology 75: 1465-1471 (IF: 8.172) Kutzelnigg A, Meshkat D, Kasper S (2010) ADHS im Erwachsenenalter. Spectrum Psychiatrie 2: 44-48 (IF: 0) Kutzelnigg A, Meshkat D, Konstantinidis A, Kasper S (2010) ADHS bei Erwachsenen. CliniCum neuropsy 6: 14-21 (IF: 0) Kutzelnigg A (2010) Was raten Sie beim adulten ADS? Fall der Woche. Ärztemagazin 45: 17-18 (IF: 0) Lanzenberger R, Hackhofer S, Kranz G, Kasper S (2010) Wie viel Gehirn braucht der Affekt? Bildgebende Verfahren und affektive Symptome bei Schizophrenie. Psychiatrie & Psychotherapie 3: 133-138 (IF: 0) Lanzenberger R, Wadsak W, Spindelegger C, Mitterhauser M, Akimova E, Mien LK, Fink M, Moser U, Savli M, Kletter K, Kasper S (2010) Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. The International Journal of Neuropsychopharmacology 13: 1129-1143 (IF: 4.874) Mendlewicz J, Massat I, Linotte S, Kasper S, Konstantinidis A, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Souery D (2010) Identification of clinical factors associated with resistance to antidepressants in bipolar depression. results from a European multicentre study. International Clinical Psychopharmacology 25: 297-301 (IF: 3.345) Meshkat D, Moser U, Kutzelnigg A, Bauer M, Kasper S, Winkler D (2010) Morbus Alzheimer: Therapiestrategien und aktuelle Entwicklungen. CliniCum neuropsy 1: 22-24 (IF: 0) Meshkat, Kutzelnigg A, Kasper S, Winkler D (2010) Ärgerattacken bei Depressionen: Geschlechtsspezifische Aspekte. Journal für Neurologie, Neurochirurgie und Psychiatrie 11: 22-25 (IF: 0) Metz V, Matzenauer C, Kammerer K, Winklbaur B, Ebner N, Radler D, Fischer G (2010) Evaluation of opioid-dependent prisoners in oral opioid maintenance therapy. Heroin Addiction & Related Clinical Problems 12: 5-16 (IF: 0) Montgomery SA, Kasper S (2010) Pharmacotherapy Update: Pregabalin in the treatment of Generalized Anxiety Disorder. Clinical Medicine Insights: Therapeutics 2: 189-202 (IF: 0) Moser U, Kasper S, Winkler D (2010) Therapie der Alzheimer Demenz: Status quo und Zukunftsperspektiven. Journal für Neurologie, Neurochirurgie und Psychiatrie 11: 72-78 (IF: 0) Moser U, Wadsak W, Spindelegger C, Mitterhauser M, Mien LK, Bieglmayer C, Kletter K, Kasper S, Lanzenberger R (2010) Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women. Neuroscience Letters 476:161-165 (IF: 1.925) Mossaheb N, Spindelegger C, Asenbaum S, Fischer P, Barnas C (2010) Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine. The World Journal of Biological Psychiatry 11:502-505 (IF: 5.564) Mühlbacher A, Kogler D, Konstantinidis A (2010) Körperdysmorphobie unter Bupropion retard? Clinicum neuropsy 4: 24-25 (IF: 0) Naderi-Heiden A, Naderi A, Naderi MM, Rahmani-Didar F, Salimi AR, Gleiss A, Kasper S, Frey R (2010) Ultra rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran. Pharmacopsychiatry 43: 130-137 (IF: 2.317) Noro M, Antonijevic I, Forray C, Kasper S, Kocabas NA, Lecrubier Y, Linotte S, Mendlewicz J, Montgomery S, Snyder L, Souery D, Verbanck P, Zohar J, Massat I (2010) 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder. International Clinical Psychopharmacology 25: 228-231 (IF: 3.345) Olajossy-Hilkesberger L, Zaborska A, Olajossy M, Godlewska B, Marmurowska-Michalowska H (2010) D3 receptor gene polymorphism and the results of Trial Making Test in patients with schizophrenia. Current Problems in Psychiatry 11: 24-26 (IF: 0) Painold A, Anderer P, Holl AK, Letmaier M, Saletu-Zyhlarz GM, Saletu B, Bonelli RM (2010) Comparative EEG mapping studies in Huntington’s disease patients and controls. Journal of Neural Transmission 117: 1307-1318 (IF: 2.259) Paul A, Kranz G, Schindl A, Kranz GS, Auff E, Sycha T (2010) Diode laser removal does not interfere with Botulinum toxin A treatment against axillary hyperhidrosis. Lasers in Surgery & Medicine 42: 211-214 (IF: 2.603) Pezawas L, Meyer-Lindenberg A (2010) Imaging genetics: Progressing by leaps and bounds. NeuroImage 53: 801-803 (IF: 5.739) Rabl U, Scharinger C, Pezawas L (2010) Personalisierte Therapie: Imaging-Genetics-Befunde bei Depression. Jatros Neurologie & Psychiatrie 2: 10-12 (IF: 0) Rabl U, Scharinger C, Mueller M, Pezawas L (2010) Imaging genetics: Implications for research on variable antidepressant drug response. Expert Review of Clinical Pharmacology 3: 471-489 (IF: 0) Radler D, Unger A, Aschauer C, Hecht A, Fischer G (2010) Opioid – Erhaltungstherapie in der Schwangerschaft unter Berücksichtigung evidenzbasierter Forschung am Beispiel der „Mother“ Studie. Sucht 56: 107-115 (IF: 0) Ritter K, Chaudhry HR, Aigner M, Zitterl W, Stompe T (2010) Mental health beliefs between culture and subjective illness experience. Neuropsychiatrie 24: 33-41 (IF: 1.381) Saletu M, Anderer P, Saletu-Zyhlarz GM, Parapatics S, Gruber G, Nia S, Saletu B (2010) Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome. Journal of Neural Transmission 117: 463-473 (IF: 2.259) Saletu A, Kloodt C, Matejka M, Anderer P, Rosales-Rodriguez S, Saletu-Zyhlarz GM (2010) Langzeiteffekte der Unterkieferprotrusionsschiene IST®. Klinische und psychometrische Untersuchungen bei Schnarchen und schlafbezogenen Atmungsstörungen. Somnologie 14: 41-47 (IF: 0) Saletu A, Parapatics S, Anderer P, Matejka M, Saletu B (2010) Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo. European Archives of Psychiatry and Clinical Neurosciences 260: 163-174 (IF: 2.747) Saletu B, Anderer P, Saletu-Zyhlarz GM (2010) EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression. Clinical EEG and Neuroscience 41: 203-210 (IF: 1.122) Saletu B, Anderer P, Saletu-Zyhlarz GM (2010) EEG mapping and tomography in drug evaluation. Medicographia 32: 190-200 (IF: 0) Scharinger C, Rabl U, Sitte HH, Pezawas L (2010) Imaging genetics of mood disorders. NeuroImage 53: 810-821 (IF: 5.739) Schlaepfer TE, George MS, Mayberg H on behalf of the WFSBP Task Force on Brain Stimulation (2010) WFSBP Guidelines on brain stimulation treatments in psychiatry. The World Journal of Biological Psychiatry 11: 2-18 (IF: 5.564) Schmid M, Kuessel L, Klein K, Metz V, Fischer G, Krampl-Bettelheim E (2010) First trimester fetal heart rate in mothers with opioid addiction. Addiction 105: 1265-1268 (IF: 3.842) Schmidt R, Marksteiner J, Dal Bianco P, Ransmayr G, Bancher C, Benke T, Wancata J, Fischer P, Leblhuber CF, Psota G, Ackerl M, Alf C, Berek K, Croy A, Delazer M, Fasching P, Frühwald T, Fruhwürth G, Fuchs-Nieder B, Gatterer G, Grossmann J, Hinterhuber H, Iglseder B, Imarhiagbe D, Jagsch C, Jellinger K, Kalousek M, Kapeller P, Ladurner G, Lampl C, Lechner A, Lingg A, Nakajima T, Rainer M, Reisecker F, Spatt J, Walch T, Uranüs M, Walter A, (2010) Konsensusstatement „Demenz 2010“ der Österreichischen Alzheimer Gesellschaft. Neuropsychiatrie 24: 67-87 (IF: 1.381) Schöpf V, Kasess C, Lanzenberger R, Fischmeister F, Windischberger C, Moser E (2010) Fully Explorative Network ICA (FENICA) on resting-state fMRI data. Journal of Neuroscience Methods 192: 207-13 (IF: 2.295) Schosser A, Fuchs K, Scharl T, Schloegelhofer M, Kindler J, Mossaheb N, Kaufmann RM, Leisch F, Kasper S, Sieghart W, Aschauer HN (2010) Interaction between Serotonin 5-HT2A receptor gene and Dopamine Transporter (DAT1) gene polymorphisms influences personality trait of Persistence in Austrian Caucasians. The World Journal of Biological Psychiatry 11: 417-424 (IF: 5.564) Schosser A, Pirlo K, Gaysina D, Cohen-Woods-S, Schalkwyk LC, Elkin A, Korszun A, Gunasinghe C, Gray J, Jones L, Meaburn E, Farmer AE, Craig IW, McGuffin P (2010) Utility of the pooling approach as applied to whole genome association scans with high-density Affymetrix microarrays. BMC Research Notes 3: 274 (IF: 0) Schosser A, Cohen S, Gaysina D, Chow PC, Martucci L, Craddock N, Farmer A, Korszun A, Gunasinghe C, Gray J, Jones L, Owen MJ, Craig IW, McGuffin P (2010) NRG1 gene in Recurrent Major Depression: a large-scale case-control association study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153: 141-147 (IF: 3.481) Schulze-Luckow A, Akimova E, Kasper S (2010) Ethnopsychopharmakologie: Bedeutung in der Klinik. CliniCum neuropsy 3: 32-35 (IF: 0) Seidel S, Aigner M, Ossege M, Pernicka E, Wildner B, Sycha T (2010) Antipsychotics for acute and chronic pain in adults. Journal of Pain and Symptom Management 39: 768-78 (IF: 2.423) Seidel S, Klösch G, Moser D, Weber M, Anderer P, Wöber C, Zeitlhofer J (2010) Morning headaches, daytime functioning and sleep problems - a population-based controlled study. Wiener Klinische Wochenschrift 122: 579-583 (IF: 0.955) Seyringer ME, Kasper S (2010) Metaanalysen - die letzte Weisheit. Psychopharmakotherapie 17: 293-294 (IF: 0.072) Sibitz I, Berger P, Freidl M, Topitz A, Krautgartner M, Spiegel W (2010) ICD-10 or DSM-
IV? Anhedonia, fatigue and depressed mood as screening symptoms for diagnosing a current
depressive episode in physically ill patients in general hospital. Journal of Affective Disorders
126: 245-251 (IF: 3.763)
Stein P, Lanzenberger R, Kasper S (2010) Veränderung der emtionalen Wahrnehmung. Jatros Neurologie & Psychiatrie 8: 36-37 (IF: 0) Unger A, Martin P, Kaltenbach K, Stine S, Heil S, Jones H, Arria A, Coyle M, Selby P, Fischer G (2010) Clinical Characteristics of Central European and North American Samples of Pregnant Women Screened for Opioid Agonist Treatment. European Addiction Research 16: 99-107 (IF: 1.233) Unger A, Jung E, Winklbaur B, Fischer G (2010) Gender issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine. Journal of Addictive Diseases 29: 217-230 (IF: 1.234) Vyssoki B, Steindl-Munda P, Ferenci, P, Walter H, Höfer P, Blüml V, Friedrich F, Kogoj D, Lesch OM (2010) Comparison of Alcohol-dependent Patients at a Gastroenterological and a Psychiatric Ward According to the Lesch Alcoholism Typology: Implications for Treatment. Alcohol and Alcoholism 45: 534-540 (IF: 2.289) Wagner A, Aizenstein H, Venkatraman VK, Bischoff-Grethe A, Fudge J, May JC, Mazurkewicz L, Frank GK, Bailer U, Fischer L, Nguyen VK, Putnam K, Kaye WH (2010) Altered striatal response to reward in bulimia nervosa after recovery. International Journal of Eating Disorders 43: 289-294 (IF: 2.797) Wancata J (2010) Versorgung von Menschen mit Depressionen. Ärztekrone 19: 18-19 (IF: 0) Wancata J, Meise U (2010) Sozialpsychiatrie: Gegensatz zu biologischer Psychiatrie und Psychotherapie? Psychiatrische Praxis 37: 317-318 (IF: 1.174) Wancata J, Meise U (2010) Soziotherapeutische Interventionen – ausreichend genützt? Neuropsychiatrie 24: 221-223 (IF: 1.381) Willeit M, Praschak-Rieder N (2010) Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. NeuroImage 53: 878-892 (IF: 5.739) Windischberger C, Lanzenberger R, Holik A, Spindelegger C, Stein P, Moser U, Gerstl F, Fink M, Moser E, Kasper S (2010) Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: A randomized cross-over study. NeuroImage 49: 1161-1170 (IF: 5.739) Winkler D (2010) Biologische Psychiatrie. Österreichische Apothekerzeitung 64: 272-274 (IF: 0) Winkler D, Aigner M (2010) Immunhypothese der Depression. Arzt & Praxis 962: 122-124 (IF: 0) Winkler D, Pjrek E, Kasper S (2010) Gen-Umwelt-Interaktionen und Gen-Umwelt-Korrelationen bei psychischen Erkrankungen. Journal für Neurologie, Neurochirurgie und Psychiatrie 11: 58-62 (IF: 0) Witte AV, Savli M, Holik A, Kasper S, Lanzenberger R (2010) Regional sex differences in grey matter volume are associated with sex hormones in the young adult human brain. NeuroImage 49: 1205-1212 (IF: 5.739) Wolfersdorf M, Möller-Leimkühler AM, Winkler D (2010) Gasteditorial: Depression beim Mann. Journal für Neurologie, Neurochirurgie und Psychiatrie 3: 7-8 (IF: 0) Wurst FM, Thon N, Aradottir S, Hartmann S, Wiesbeck G, Lesch O, Skala K, Wolfersdorfer M, Weinmann W, Alling C (2010) Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addiction Biology 15: 88-95 (IF: 4.728) Zanki M, Metz V, Fischer (2010) Suchterkrankungen – Überblick und aktuelle Forschungsergebnisse. Addictions – An Overview and Current Scientific Results. Psychologie in Österreich 2/3: 118-127 (IF: 0) Zeitlhofer J, Seidel S, Klösch G, Moser D, Anderer P, Machatschke I, Bolitschek J, Fugger B, Holzinger B, Kerbl R, Lehofer M, Mallin W, Pavelka R, Popovic R, Saletu A, Saletu B, Högl B (2010) Die Schlafgewohnheiten der Österreicher. Erste Ergebnisse einer repräsentativen Umfrage. Somnologie 14: 6-14 (IF: 0) Zeitlhofer J, Seidel S, Klösch G, Moser D, Anderer P, Saletu B, Bolitschek J, Popovic R, Lehofer M, Mallin W, Fugger B, Holzinger B, Kerbl R, Saletu A, Machatschke I, Pavelka R, Högl B (2010) Sleep habits and sleep complaints in Austria: current self-reported data on sleep behaviour, sleep disturbances and their treatment. Acta Neurologica Scandinavica 122: 398-403 (IF: 2.324)

Source: http://biologicalpsychiatry.meduniwien.ac.at/fileadmin/psychiatrie/Div._Dateien/Liste_der_Publikationen_2010.pdf

Doi:10.1016/j.cfp.2004.03.010

Irritable bowel syndrome (IBS) is one of the most common conditionsthat is encountered in general medical practices It has the potentialfor protean manifestations, but generally is characterized by abdominalpain, bloating, and disturbed defecation. Based upon survey data from thegeneral population, the prevalence of symptoms that are suggestive of IBSis between 14% and 24% in women and from 5%

Cosmetic dentistry

COSMETIC DENTISTRY Teeth Whitening Whitening of teeth is performed for patients who desire a brighter smile. As the name suggests, teeth whitening is a procedure used to lighten the color of teeth. You should look for a whitening procedure that is: Teeth darkened from coffee, tea or smoking Discoloration of teeth by the deterioration of a tooth’s nerve **Stains caused by te

Copyright © 2010-2014 Medical Articles